Healthcare provider profile · identity verified

Irina M Pines, MD

Internal Medicine · DENVER, CO · NPI 1124134697

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	487	89
Losartan Potassium	Losartan Potassium	456	74
Potassium Chloride	Potassium Chloride	291	51
Sertraline Hcl	Sertraline Hcl	290	47
Amlodipine Besylate	Amlodipine Besylate	254	48
Omeprazole	Omeprazole	244	45
Metformin Hcl	Metformin Hcl	243	38
Diclofenac Sodium	Diclofenac Sodium	208	50
Levothyroxine Sodium	Levothyroxine Sodium	203	28
Lisinopril	Lisinopril	196	38
Pantoprazole Sodium	Pantoprazole Sodium	186	40
Metoprolol Succinate	Metoprolol Succinate	181	28
Hydrochlorothiazide	Hydrochlorothiazide	163	37
Tamsulosin Hcl	Tamsulosin Hcl	162	29
Alendronate Sodium	Alendronate Sodium	159	25
Gabapentin	Gabapentin	149	21
Carvedilol	Carvedilol	122	16
Metoprolol Tartrate	Metoprolol Tartrate	122	20
Januvia	Sitagliptin Phosphate	116	15
Rosuvastatin Calcium	Rosuvastatin Calcium	114	22
Glipizide	Glipizide	109	16
Memantine Hcl	Memantine Hcl	109	19
Zolpidem Tartrate	Zolpidem Tartrate	108	24
Furosemide	Furosemide	96	18
Atenolol	Atenolol	95	14
Xarelto	Rivaroxaban	93	14
Clopidogrel	Clopidogrel Bisulfate	88	12
Ozempic	Semaglutide	87	11
Simvastatin	Simvastatin	76	17
Tramadol Hcl	Tramadol Hcl	75	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	suppressed
Spironolactone	Spironolactone	67	11
Dexlansoprazole Dr	Dexlansoprazole	65	suppressed
Finasteride	Finasteride	64	suppressed
Eliquis	Apixaban	62	suppressed
Allopurinol	Allopurinol	60	suppressed
Creon	Lipase/Protease/Amylase	60	16
Hydralazine Hcl	Hydralazine Hcl	57	suppressed
Famotidine	Famotidine	54	suppressed
Clonidine Hcl	Clonidine Hcl	51	11
Ezetimibe	Ezetimibe	51	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	51	17
Ibuprofen	Ibuprofen	49	21
Alprazolam	Alprazolam	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	43	13
Linzess	Linaclotide	43	11
Escitalopram Oxalate	Escitalopram Oxalate	42	suppressed
Donepezil Hcl	Donepezil Hcl	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Clonazepam	Clonazepam	38	suppressed
Valsartan	Valsartan	38	suppressed
Vascepa	Icosapent Ethyl	38	suppressed
Glipizide Er	Glipizide	37	suppressed
Hydrocortisone	Hydrocortisone	34	suppressed
Metformin Hcl Er	Metformin Hcl	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Invokana	Canagliflozin	32	suppressed
Jardiance	Empagliflozin	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	17
Procto-Med Hc	Hydrocortisone	30	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Ammonium Lactate	Ammonium Lactate	25	12
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Lorazepam	Lorazepam	23	suppressed
Nitroglycerin	Nitroglycerin	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	suppressed
Tradjenta	Linagliptin	21	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Lidocaine	Lidocaine	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Naproxen	Naproxen	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Fluocinonide	Fluocinonide	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Temazepam	Temazepam	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Methimazole	Methimazole	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	11	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Digoxin	Digoxin	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Ramipril	Ramipril	11	suppressed
Tirosint	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error